- Home
- YORW vs LAB Comparison
YORW vs LAB Comparison
Compare YORW & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- LAB
- Stock Information
- Founded
- YORW 1816
- LAB 1999
- Country
- YORW United States
- LAB United States
- Employees
- YORW N/A
- LAB N/A
- Industry
- YORW Water Supply
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- YORW Utilities
- LAB Industrials
- Exchange
- YORW Nasdaq
- LAB Nasdaq
- Market Cap
- YORW 475.9M
- LAB 562.1M
- IPO Year
- YORW N/A
- LAB 2011
- Fundamental
- Price
- YORW $34.39
- LAB $1.18
- Analyst Decision
- YORW
- LAB Strong Buy
- Analyst Count
- YORW 0
- LAB 3
- Target Price
- YORW N/A
- LAB $2.88
- AVG Volume (30 Days)
- YORW 71.3K
- LAB 1.4M
- Earning Date
- YORW 05-06-2025
- LAB 05-07-2025
- Dividend Yield
- YORW 2.55%
- LAB N/A
- EPS Growth
- YORW N/A
- LAB N/A
- EPS
- YORW 1.42
- LAB N/A
- Revenue
- YORW $74,959,000.00
- LAB $174,432,000.00
- Revenue This Year
- YORW $7.50
- LAB N/A
- Revenue Next Year
- YORW $6.33
- LAB $12.77
- P/E Ratio
- YORW $24.27
- LAB N/A
- Revenue Growth
- YORW 5.53
- LAB 64.03
- 52 Week Low
- YORW $29.86
- LAB $0.99
- 52 Week High
- YORW $41.96
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- YORW 55.84
- LAB 49.14
- Support Level
- YORW $32.61
- LAB $1.05
- Resistance Level
- YORW $35.31
- LAB $1.21
- Average True Range (ATR)
- YORW 0.67
- LAB 0.08
- MACD
- YORW 0.00
- LAB 0.01
- Stochastic Oscillator
- YORW 65.93
- LAB 61.90
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and two wastewater treatment systems. The company operates within its franchised territory, which covers more than 54 municipalities within York County, Pennsylvania.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.